Skip to main content

You are here

09/15/2014

WASHINGTON, Sept. 15, 2014 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) has entered into a definitive transaction agreement with Nobel Biocare Holding AG ("Nobel Biocare") (SIX Swiss Exchange: NOBN) pursuant to which Danaher Corporation or one of its direct or indirect subsidiaries ("Danaher") will commence a tender offer for all publicly held registered shares of Nobel Biocare in an all-cash transaction valued at approximately $2.2 billion.  The deal is expected to widen Danaher's market presence in the global dental industry and allow Nobel Biocare to accelerate its strategic objectives and future growth.

Under the terms of the transaction agreement, Danaher will commence a voluntary all-cash public tender offer of CHF 17.10 per Nobel Biocare share to purchase all of Nobel Biocare's publicly held registered shares.  The pre-announcement of the public tender offer is published today. The offer prospectus is expected to be published on or around October 1, 2014 and the offer period during which Nobel Biocare shareholders may tender their registered shares is expected to start on or around October 16, 2014.  Headquartered in

09/09/2014

WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will present at the Morgan Stanley Laguna Conference in Dana Point, California on Tuesday, September 16 at 8:00 a.m. PT.  The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com. Â

09/09/2014

WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on October 31, 2014 to holders of record on September 26, 2014.

09/02/2014

WASHINGTON, Sept. 2, 2014 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that the Company's Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President and Chief Executive Officer and a member of the Board of Directors, effective September 9, 2014. Mr. Joyce's predecessor, H. Lawrence Culp, Jr., will transition to a senior advisory role.

Steven M. Rales, Chairman of the Board of Dir

06/26/2014

Washington, D.C., June 26, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2014 on Thursday, July 17, 2014 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

06/19/2014

WASHINGTON, D.C., June 19, 2014 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on June 24, 2014 beginning at 1:30 p.m. PT and concluding at approximately 4:00 p.m PT.  The link to the webcast can be found on Danaher's website, www.danaher.com, under the "Investors" heading. A replay of the video webcast will be available following the presentation.

06/04/2014

Washington, D.C., June 4, 2014 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President, Thomas P. Joyce, will present at the Goldman Sachs Global Healthcare Conference in Ranch Palos Verdes, California on Tuesday, June 10 at 8:00 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.

05/14/2014

Washington, D.C., May 13, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 19 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.

05/13/2014

WASHINGTON, D.C., May 13, 2014 - Danaher Corporation (NYSE: DHR) has been notified of an unsolicited "mini-tender offer" made by TRC Capital Corporation (TRC) to Danaher stockholders to purchase up to 2,000,000 shares of Danaher common stock at a price of $69.70 per share. TRC's offer price represents a discount of $3.11 per share, or 4.27 percent, below Danaher's closing price of $72.81 on May 7, 2014, the date of the offer.  The closing price of Danaher's common stock on May 13, 2014 was $75.63 per share.

News & Releases